Softwr

Healthcare · head to head

Lunit vs Meru Health

Lunit logo

Lunit

Healthcare

FDA cleared and CE marked AI for mammography, tomosynthesis and chest radiography

From
On request
Rated
-
Full reviewWebsite
Meru Health logo

Meru Health

Healthcare

Twelve week therapist led mental health programme combining an app, a clinician and HRV biofeedback

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Lunit the regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.; Meru Health the programme is twelve weeks and then it ends, which fits an episode of treatment but not a chronic condition needing maintenance, so relapse after week twelve lands on whatever pathway the buyer has funded next, if any.
  • They diverge on capability: Lunit covers Lunit INSIGHT MMG, Meru Health covers Twelve week structured programme.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Lunit and Meru Health actually diverge.

Attributes where Lunit and Meru Health differ
AttributeLunitMeru Health
PlatformsWebWeb, iOS, Android

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Lunit

  • Lunit INSIGHT MMG
  • Lunit INSIGHT DBT
  • Lunit INSIGHT CXR
  • Volpara density assessment
  • Volpara RiskPathways
  • Volpara dose tracking
  • PACS and mammography workstation integration

Only in Meru Health

  • Twelve week structured programme
  • Licensed therapist
  • Psychiatric consultation
  • HRV biofeedback device
  • Daily in app practice
  • Meru Health Advanced
  • Payer contracting
  • Outcome measurement

What people use each for

The jobs each tool is most often brought in to do.

Lunit

  • A national breast screening programme evaluating AI as a second reader to reduce double reading workload where two human readers are currently mandatednot Meru Health
  • A breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on DBT specificallynot Meru Health
  • An American breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what Volpara is bought fornot Meru Health
  • A tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise filmsnot Meru Health

Meru Health

  • A health plan that wants a mental health intervention it can underwrite as a bounded episode rather than an open ended benefitnot Lunit
  • An employer whose staff need treatment rather than wellbeing content, with a therapist and a prescriber in one pathwaynot Lunit
  • A member who needs medication review alongside therapy, which most app based mental health products cannot providenot Lunit
  • A health system seeking to offload moderate depression and anxiety from a psychiatry service with long waitsnot Lunit

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Lunit

  • The regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • Detection AI changes recall rates in screening, and the downstream cost of additional diagnostic workup lands on the programme rather than on the software budget, which is the cost most screening business cases omit.
  • Performance is sensitive to the mammography vendor and acquisition protocol, so published results from a Hologic estate do not transfer to a GE or Siemens estate without local validation the buyer must fund.
  • MMG, DBT and CXR are licensed separately and Volpara modules are separate again, so a breast centre wanting detection, density and risk pathways is assembling four line items rather than buying one product.
  • Using AI as a replacement for one of two human readers is a workforce and liability decision that regulators and professional bodies treat differently in each country, so the saving that justifies the purchase may not be permitted where you operate.

Meru Health

  • The programme is twelve weeks and then it ends, which fits an episode of treatment but not a chronic condition needing maintenance, so relapse after week twelve lands on whatever pathway the buyer has funded next, if any.
  • Whether the employer, the health plan or the member pays depends on the contract route, and members frequently do not know which applies to them until they receive a bill or discover they do not.
  • A structured programme demands daily engagement, and members who cannot sustain that get much less than the outcome data implies, because the published results reflect members who completed.
  • The heart rate variability device is a differentiator but also a logistics and support burden, adding shipping, returns and device support to what would otherwise be a software deployment.
  • Meru is small relative to Lyra, Spring Health and the large payer owned behavioural health offerings, so an employer choosing it takes on more vendor concentration risk in a category that has seen frequent consolidation.

Pricing, plan by plan

Lunit

On request
  • Lunit INSIGHT$undefined/year
    • Priced per study or per annual examination volume by product
    • MMG, DBT and CXR licensed separately
    • Volpara density and RiskPathways modules quoted separately

Meru Health

On request
  • Meru Health$undefined/year
    • Contracted per completed programme or per member per month depending on buyer type
    • Health plan contracts bill differently from employer contracts
    • Member cost sharing depends on whether access comes via insurance or an employer benefit

Which should you pick?

Choose Lunit if

  • You need lunit insight mmg.
  • You also want lunit insight dbt.
Lunit review

Choose Meru Health if

  • You need twelve week structured programme.
  • You work on Web, iOS, Android.
  • You also want licensed therapist.
Meru Health review

Questions people ask

Is Lunit or Meru Health better?
Neither clearly leads. Lunit starts at On request and Meru Health at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Lunit or Meru Health?
Lunit starts at On request and Meru Health at On request.
Does Lunit or Meru Health run on more platforms?
Lunit runs on Web. Meru Health runs on Web, iOS, Android.
What is Lunit best used for?
Lunit is most often used for a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated, a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically, an american breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what volpara is bought for, a tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise films. Of those, a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated and a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically are not what Meru Health is typically brought in for.
What can Lunit do that Meru Health cannot?
Lunit covers Lunit INSIGHT MMG, Lunit INSIGHT DBT, Lunit INSIGHT CXR, Volpara density assessment. Meru Health covers Twelve week structured programme, Licensed therapist, Psychiatric consultation, HRV biofeedback device.

Answered from the vendors’ own pages

Lunit: Is Lunit FDA cleared?

Yes for specific products. INSIGHT MMG, INSIGHT DBT and INSIGHT CXR Triage hold FDA 510(k) clearances. INSIGHT Risk, the five year risk prediction model, has been filed but was not cleared at the time of writing.

Meru Health: Is Meru Health still operating?

Yes. It launched Meru Health Advanced in May 2026 and expanded its Harvard Pilgrim Health Care collaboration in 2025. It has not wound down.

Lunit: Can Lunit replace a second human reader in screening?

That depends entirely on your jurisdiction and professional body guidance, not on the software. The CE mark permits clinical use; it does not authorise a workforce model.

Meru Health: How long is the programme?

Around twelve weeks. It is a bounded treatment episode rather than open ended therapy, which is why health plans will contract for it.

Lunit: What did the Volpara acquisition add?

Volumetric breast density measurement, dose tracking and RiskPathways high risk programme management, which are the things American breast centres buy for density notification compliance rather than for detection.

Meru Health: Who pays?

It depends on the contract. Meru sells to both health plans and employers, and member cost sharing differs between those routes. Confirm which applies before enrolling.

Lunit: Is pricing published?

No. It is quoted per study or per annual volume, by product, with on premises and cloud priced differently.

Meru Health: Does it include medication?

Psychiatric consultation is part of the programme where medication is indicated, which distinguishes it from app plus coaching products that cannot prescribe.

Share

Related pages

More on Lunit

More on Meru Health

Keep looking

Other head to heads